Invasive Group B Streptococcus (GBS) Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Invasive Group B Streptococcus (GBS) Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06833957

Preparing for Maternal GBS Vaccine Trials in Africa

Infections are one of the key causes of newborn deaths. Among them, Group B Streptococcus (GBS) is the leading cause of sepsis and bacterial meningitis in the f…

Kenya, Malawi18,100 participantsStarted 2025-03-01

All recent trials (8 shown)

Not Yet RecruitingNot Applicable

NCT06896526

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

The goal of this registry is to collect and store important medical and non-health information on children from 0 to 18 years of age affected by early- (up to 2…

Location not specified10,000 participantsStarted 2025-04-01

UnknownNot Applicable

NCT04653948

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Maternal immunisation is an evolving field that deserves special attention given its potential to have a significant positive impact on the health of women and…

Uganda3,423 participantsStarted 2019-10-01

CompletedNot Applicable

NCT01888471

Invasive Group B Streptococcus (GBS) Disease

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Preparing for Maternal GBS Vaccine Trials in Africa

All recent trials (8 shown)

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Preparing for Maternal GBS Vaccine Trials in Africa

All recent trials (8 shown)

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease…

GBS Sero-correlate of Protection

Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose…

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose…